Latest Articles
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology
Published: June 19, 2026, 5:05 p.m.
Data Updates Shift Treatment Standards in Gyn-Oncology - Medscape
Data Updates Shift Treatment Standards in Gyn-Oncology Medscape
Published: June 17, 2026, 1:18 p.m.
Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer - Targeted Oncology
Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer Targeted Oncology
Published: May 29, 2026, 10:11 p.m.
Sakar Healthcare, Zydus Lifesciences join hands to expand oncology supply across GCC markets - IndiaMedToday
Sakar Healthcare, Zydus Lifesciences join hands to expand oncology supply across GCC markets IndiaMedToday
Published: May 25, 2026, 4:27 a.m.
Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: May 21, 2026, 12:46 p.m.
Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer - Targeted Oncology
Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer Targeted Oncology
Published: May 18, 2026, 1:33 p.m.
Adenomyosis Independently Increases Risk for Endometrial Proliferative Disorders - Oncology Nurse Advisor
Adenomyosis Independently Increases Risk for Endometrial Proliferative Disorders Oncology Nurse Advisor
Published: May 4, 2026, 4 a.m.
Five Under 5: Top Oncology Videos for the Week of 4/12 - OncLive
Five Under 5: Top Oncology Videos for the Week of 4/12 OncLive
Published: April 19, 2026, 10:58 a.m.
Trial Marks “Major Step in Progress in Endometrial Cancer Research” - Oncology News Central
Trial Marks “Major Step in Progress in Endometrial Cancer Research” Oncology News Central
Published: April 16, 2026, 10:14 a.m.
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma - Oncology Nursing News
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma Oncology Nursing News
Published: April 15, 2026, 4:59 p.m.
Link copied to clipboard!